ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RXRX Recursion Pharmaceuticals Inc

9.5197
0.9197 (10.69%)
Last Updated: 18:44:04
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 5.33M7.67M13.16M13.68M12.13M11.02M10.53M10.89M
Operating Income -55.98M-66.19M-62.57M-60.98M-69.87M-81.72M-99.55M-98.93M
Pre Tax Income -55.98M-65.56M-60.45M-57.49M-65.33M-76.73M-93.02M-97.06M
Net Income -55.98M-65.56M-60.45M-57.49M-65.33M-76.73M-93.02M-93M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -56.05M-66.2M-62.34M-61.16M-69.97M-81.66M-98.01M-101.55M
EBITDA -53.21M-63.41M-59.75M-54.77M-64.91M-76.23M-91.95M-91.38M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 2.32M3.96M10.18M39.84M44.58M
Operating Income -62.44M-84.38M-182.78M-245.73M-350.06M
Pre Tax Income -61.88M-87.01M-186.48M-239.48M-332.13M
Net Income -61.88M-87.01M-186.48M-239.48M-328.07M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -4.29-5.849-0.548-0.703-0.76
EBIT -62.43M-84.87M-182.77M-245.68M-351.15M
EBITDA -58.9M-79.3M-173.67M-231.14M-324.47M

Your Recent History

Delayed Upgrade Clock